发明名称 MODIFIED GP140 ENVELOPE POLYPEPTIDES OF HIV-1 ISOLATES, COMPOSITIONS, STABILIZED TRIMERIC COMPLEXES, AND USES THEREOF
摘要 This invention provides a modified gpl40 envelope polypeptide of an HIV-1 isolate comprising a gpl20 polypeptide portion comprising consecutive amino acids and a gp41 ectodomain polypeptide portion comprising consecutive amino acids, said gp41 ectodomain polypeptide portion being modified to comprise isoleucine (I) at an amino acid position equivalent to amino acid position 535; glutamine (Q) at an amino acid position equivalent to amino acid position 543; serine (S) at an amino acid position equivalent to amino acid position 553; lysine (K) at an amino acid position equivalent to amino acid position 567; and arginine (R) at an amino acid position equivalent to amino acid position 588, the amino acid positions being numbered by reference to the HIV-1 isolate KNH1144. This invention also provides nucleic acids encoding such a polypeptide, vectors, host cells, trimeric complexes and compositions thereof. Also provided are antibodies generated against the modified polypeptides and trimeric complexes, and methods of using the modified polypeptides, compositions and trimeric complexes.
申请公布号 WO2008063331(A3) 申请公布日期 2008.11.06
申请号 WO2007US22227 申请日期 2007.10.17
申请人 PROGENICS PHARMACEUTICALS, INC.;CORNELL RESEARCH FOUNDATION, INC.;DEY, ANTU, K.;MOORE, JOHN, P.;OLSON, WILLIAM, C.;IYER, SAI PRASAD, N.;KANG, KENNETH;FRANTI, MICHAEL 发明人 DEY, ANTU, K.;MOORE, JOHN, P.;OLSON, WILLIAM, C.;IYER, SAI PRASAD, N.;KANG, KENNETH;FRANTI, MICHAEL
分类号 A61K39/21;A61K39/42;C07H21/04 主分类号 A61K39/21
代理机构 代理人
主权项
地址